Pulike becomes the company that knows the most about Porcine Circovirus

We have been focusing on the research of porcine circovirus vaccine series for ten years, constantly upgrading and iterating from R&D, process and adjuvant, etc. From September 27, 2010, the first domestic porcine circovirus inactivated vaccine "Yuanjian" was launched, to February 9, 2020, PULIKE porcine circovirus type 2 and Haemophilus parvum It can be said that Pulike is the leader in the development and innovation of porcine circovirus vaccine, and has greatly promoted the level of animal vaccine development in China. The following is the ten-year development and upgrading history of the live swine circovirus vaccine.

◆ On September 27, 2010, the first domestic inactivated porcine circovirus vaccine, "Yuanjian", was launched by Pulike.
On August 25, 2016, Huizhong Biological, a wholly-owned subsidiary of Pulike, declared the first domestic inactivated whole virus porcine circovirus type 2 vaccine (SH strain, II) with Freemix Aqueous Compound Immunologic Adjuvant, and obtained the public announcement of the new veterinary drug certificate from the Ministry of Agriculture and Rural Affairs.
◆ On November 19, 2017, the first pure virus-like particle porcine circovirus type 2 genetically engineered subunit vaccine (of E. coli origin) in China, "Yuankexin", developed by Pulike for seven years, was launched.
◆ On November 6, 2018, the world's first water adjuvanted porcine circovirus type 2 and Mycoplasma pneumoniae diphasic vaccine, which was developed by our subsidiary Huizhong Biologicals based on the National Veterinary Drug Engineering and Technology Research Center over 8 years, was launched.
On February 9, 2020, the world's first water adjuvanted porcine circovirus type 2 and Mycoplasma pneumoniae diphtheriae inactivated vaccine (SH strain + JS strain type 4 + ZJ strain type 5) was launched on the market.

From the first in China to the whole series of circovirus, from common adjuvant to water adjuvant, Pulike has completed the comprehensive leading and upgrading of circovirus vaccine series, and become one of the most professional animal protection enterprises in the research and development of circovirus vaccine series.